Syntec Optics Holdings has rapidly appreciated, driven by military contracts, a $21.5M equity raise, and imminent Russell 3000 Index inclusion. OPTX's recent capital infusion eliminated liquidity risk, extended its cash runway to over four years, and enabled strategic acquisitions and operational expansion. Despite Q1-2026 revenue and earnings declines, management expects Q2 sales to exceed $7.5M, underpinned by defense and space optics growth.